NO20050885D0 - Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre - Google Patents

Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre

Info

Publication number
NO20050885D0
NO20050885D0 NO20050885A NO20050885A NO20050885D0 NO 20050885 D0 NO20050885 D0 NO 20050885D0 NO 20050885 A NO20050885 A NO 20050885A NO 20050885 A NO20050885 A NO 20050885A NO 20050885 D0 NO20050885 D0 NO 20050885D0
Authority
NO
Norway
Prior art keywords
benzazepin
dihydro
synthesis
compounds
new process
Prior art date
Application number
NO20050885A
Other languages
English (en)
Other versions
NO329438B1 (no
NO20050885L (no
Inventor
Jean-Pierre Lecouve
Daniel Brigot
Jean-Michel Lerestif
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20050885D0 publication Critical patent/NO20050885D0/no
Publication of NO20050885L publication Critical patent/NO20050885L/no
Publication of NO329438B1 publication Critical patent/NO329438B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
NO20050885A 2004-04-13 2005-02-18 Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre NO329438B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403829A FR2868776B1 (fr) 2004-04-13 2004-04-13 Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (3)

Publication Number Publication Date
NO20050885D0 true NO20050885D0 (no) 2005-02-18
NO20050885L NO20050885L (no) 2005-10-14
NO329438B1 NO329438B1 (no) 2010-10-18

Family

ID=34941960

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050885A NO329438B1 (no) 2004-04-13 2005-02-18 Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre

Country Status (33)

Country Link
US (1) US7074920B2 (no)
EP (1) EP1589014B1 (no)
JP (2) JP4511970B2 (no)
KR (1) KR100636500B1 (no)
CN (1) CN1332951C (no)
AR (1) AR047686A1 (no)
AT (1) ATE375339T1 (no)
AU (1) AU2005200860B2 (no)
BR (1) BRPI0500478B8 (no)
CA (1) CA2496721C (no)
CY (1) CY1107101T1 (no)
DE (1) DE602005002776T2 (no)
DK (1) DK1589014T3 (no)
EA (1) EA007744B1 (no)
ES (1) ES2294652T3 (no)
FR (1) FR2868776B1 (no)
GE (1) GEP20074137B (no)
HK (1) HK1079776A1 (no)
HR (1) HRP20070503T3 (no)
MA (1) MA27599A1 (no)
ME (1) ME01402B (no)
MX (1) MXPA05003695A (no)
MY (1) MY141223A (no)
NO (1) NO329438B1 (no)
NZ (1) NZ538327A (no)
PL (1) PL1589014T3 (no)
PT (1) PT1589014E (no)
RS (1) RS50546B (no)
SG (1) SG116573A1 (no)
SI (1) SI1589014T1 (no)
UA (1) UA81772C2 (no)
WO (1) WO2005111026A1 (no)
ZA (1) ZA200501467B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868776B1 (fr) * 2004-04-13 2008-04-18 Servier Lab Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
WO2008146308A2 (en) 2007-05-30 2008-12-04 Ind-Swift Laboratories Limited Process for the preparation of ivabradine hydrochloride and polymorph thereof
ES2402765T3 (es) 2008-12-22 2013-05-08 Krka, D.D., Novo Mesto Procedimiento de preparación de ivabradina
SI2902384T1 (en) 2010-02-12 2018-03-30 Krka, D.D., Novo Mesto The form of ivabradine hydrochloride
FR2956401B1 (fr) * 2010-02-17 2012-02-03 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (de) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
DE3418270A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0204349A3 (de) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3519735A1 (de) * 1985-06-01 1986-12-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JP2568416B2 (ja) * 1986-11-04 1997-01-08 大塚製薬株式会社 ヒドロフルオレン誘導体
JPH0495078A (ja) * 1990-08-08 1992-03-27 Nippon Shoji Kk ピリミドン誘導体の製造法、そのための中間体
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
TW279860B (no) * 1993-11-12 1996-07-01 Ciba Geigy Ag
FR2868776B1 (fr) * 2004-04-13 2008-04-18 Servier Lab Nouveau procede de synthese de derives de la 1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
DE602005002776D1 (de) 2007-11-22
US7074920B2 (en) 2006-07-11
ES2294652T3 (es) 2008-04-01
BRPI0500478A (pt) 2005-11-16
KR100636500B1 (ko) 2006-10-18
US20050227962A1 (en) 2005-10-13
AR047686A1 (es) 2006-02-01
EP1589014B1 (fr) 2007-10-10
JP2010043096A (ja) 2010-02-25
KR20060042120A (ko) 2006-05-12
EA007744B1 (ru) 2006-12-29
CY1107101T1 (el) 2012-10-24
PT1589014E (pt) 2007-12-13
AU2005200860A1 (en) 2005-10-27
ZA200501467B (en) 2005-11-30
EP1589014A1 (fr) 2005-10-26
EA200500237A1 (ru) 2005-10-27
RS50546B (sr) 2010-05-07
SI1589014T1 (sl) 2008-02-29
JP2005298479A (ja) 2005-10-27
ME01402B (me) 2010-05-07
ATE375339T1 (de) 2007-10-15
NZ538327A (en) 2005-11-25
DE602005002776T2 (de) 2008-08-28
CN1683342A (zh) 2005-10-19
AU2005200860B2 (en) 2010-08-05
DK1589014T3 (da) 2008-02-25
HRP20070503T3 (en) 2007-12-31
MY141223A (en) 2010-03-31
HK1079776A1 (en) 2006-04-13
FR2868776B1 (fr) 2008-04-18
MXPA05003695A (es) 2006-01-24
CA2496721C (fr) 2010-09-07
BRPI0500478B1 (pt) 2019-04-02
UA81772C2 (uk) 2008-02-11
WO2005111026A1 (fr) 2005-11-24
JP4511970B2 (ja) 2010-07-28
NO329438B1 (no) 2010-10-18
CN1332951C (zh) 2007-08-22
NO20050885L (no) 2005-10-14
SG116573A1 (en) 2005-11-28
GEP20074137B (en) 2007-06-25
MA27599A1 (fr) 2005-11-01
BRPI0500478B8 (pt) 2021-05-25
PL1589014T3 (pl) 2008-01-31
FR2868776A1 (fr) 2005-10-14
CA2496721A1 (fr) 2005-10-13

Similar Documents

Publication Publication Date Title
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
EG25197A (en) Process for the manufacture of 1,2-dichloroethane
EG25196A (en) Process for the manufacture of 1,2-Dichloroethane
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
NO20043345L (no) Fremgangsmate for fremstilling av hydrokarboner
ATE486597T1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
PT1831265E (pt) Processo para a produção de 1,2-dicloroetano
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
NO20052262D0 (no) Fremgangsmate til fremstilling av 4-substituerte 2,2,6,6-tetrametyl-piperidin-N-oksy- og 2,2,6,6-tetrametyl-piperidin-N-hydroksy-forbindelser
PL1807395T3 (pl) Sposób syntezy n-alkoksyamin
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
NO20043586L (no) Fremgangsmate for fremstilling av organiske forbindelser
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
NO20050885L (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
PL374461A1 (pl) Sposób otrzymywania pochodnych 13,14-dihydro-PGF
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20044050L (no) Fremgangsmate for syntese av chirale N-aryl-piperaziner
EP1883628A4 (en) IMPROVED PROCESS FOR THE PREPARATION OF 3,5-DIETHYL-1,2-DIHYDRO-1-PHENYL-2-PROPYLPYRIDINE
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO20052392L (no) Fremgangsmate for fremstilling av acetylenforbindelser.
ITMI20030346A1 (it) Procedimento per la produzione di mesitilene.